Ionis Pharmaceuticals - Precio De Mercado

IONS

61.28

Cambio Diario:

-0.11%

Anual:

-0.24%

Precio Día Año
Astellas Pharma 1,659.50 -2.50 -0.15% -11.82%
Agios Pharmaceuticals 45.67 -0.28 -0.61% -11.41%
Alnylam Pharmaceuticals 166.36 1.29 0.78% 39.40%
Arena Pharmaceuticals 80.50 -0.06 -0.07% 73.96%
Arrowhead Research 80.74 -2.12 -2.56% 41.38%
BioCryst Pharmaceuticals 8.80 0.21 2.44% 210.95%
Bluebird Bio 50.53 -1.32 -2.55% -48.16%
BioMarin Pharmaceutical 82.97 1.61 1.98% -6.91%
Dicerna Pharmaceuticals 23.57 -0.78 -3.20% 11.28%
Esperion Therapeutics 25.55 -1.20 -4.49% -56.30%
Exelixis 23.73 -0.06 -0.23% 16.07%
GW Pharmaceuticals 135.73 -2.10 -1.52% 13.94%
Halozyme Therapeutics 47.43 0.38 0.81% 135.62%
Intercept Pharmaceuticals 27.45 -1.79 -6.12% -75.10%
Moderna Inc 129.65 -0.07 -0.05% 517.09%
Mirati Therapeutics 214.47 0.72 0.34% 120.13%
Neurocrine Biosciences 107.69 -1.60 -1.46% 1.28%
Nektar Therapeutics 16.98 -0.82 -4.61% -28.95%
Novartis 84.78 -0.52 -0.61% -8.56%
Omeros 18.06 0.07 0.39% 22.07%
Pfizer 36.70 -0.05 -0.14% -9.63%
PTC Therapeutics 68.49 -0.23 -0.33% 30.53%
Ultragenyx Pharmaceutical 137.97 -1.90 -1.36% 126.63%
Regeneron Pharmaceuticals 517.93 0.02 0.004% 34.33%
Roche Holding 317.00 0.35 0.11% -3.40%
Sarepta Therapeutics 90.32 0.42 0.47% -30.68%
Vertex Pharmaceuticals 225.55 -0.57 -0.25% -4.23%


IONS:US
Bienes
Efectivo Y Equivalentes
El Costo De Ventas
Activos Circulantes
Pasivo Circulante
DEUDA
EBIT
EBITDA
Empleados
Eps Ganancias Por Acción
Capital Y Las Reservas
Beneficio Bruto En Ventas
Los Gastos Financieros De La Deuda
Capital De Préstamo
Capitalización De Mercado
Lngresos Netos
Los Gastos De Explotación
Beneficio Operativo
Beneficio Antes De Impuestos
Ingresos Por Ventas
Gastos De Venta Y Administración
Valores
Acreedores Comerciales
Deudores Comerciales